|
Summary
November 2007, Vol. 7, No. 11, Pages 1689-1703
, DOI 10.1517/14712598.7.11.1689
T-regulatory lymphocytes and chronic viral hepatitisSimon M RushbrookUniversity of Cambridge School of Clinical Medicine, Department of Medicine, Box 157, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK +44 0 1223 586614; +44 0 1223 216111; gja1000@doctors.org.uk Both hepatitis B virus (HBV) and hepatitis C virus (HCV) can cause persistent viral infection in humans. Chronic infection is associated with a risk of cirrhosis and hepatocellular carcinoma. The cause of chronic infection is unknown. A large body of evidence suggests that a failure of the adaptive immune response is critical in the establishment of chronic infection. Recently a new group of T cells (T-regulatory cells), that express CD4+CD25+ and Foxp3, which can inhibit the cellular (CD4+/CD8+) immune response have been described. In this review the authors explore the thoughts regarding immune responses to HBV and HCV infections and the role of these T-regulatory cells in relation to the pathogenesis of chronic HBV and HCV infection and the potential for therapeutic intervention. Forward Links to Citing ArticlesAlbert S. Reece. (2009) Chronic viral hepatitis is a significant contributor to the immunosenescent phenotype of parenteral drug addiction. Addiction Biology 14:2, 214-226 Online publication date: 1-May-2009. CrossRef Esther Unitt, William Gelson, Susan E. Davies, Nicholas Coleman, Graeme J. M. Alexander. (2009) Minichromosome maintenance protein-2-positive portal tract lymphocytes distinguish acute cellular rejection from hepatitis C virus recurrence after liver transplantation. Liver Transplantation 15:3, 306-312 Online publication date: 1-Apr-2009. CrossRef L. Alvarez-Lajonchere, N. H. Shoukry, B. Grá, Y. Amador-Cañizares, F. Helle, N. Bédard, I. Guerra, C. Drouin, J. Dubuisson, E. E. González-Horta, G. Martínez, J. Marante, Z. Cinza, M. Castellanos, S. Dueñas-Carrera. (2009) Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial. Journal of Viral Hepatitis 16:3, 156-167 Online publication date: 1-Apr-2009. CrossRef |
|





Author for correspondence
TOC Alert